Renee Altman, DPM
Podiatrist · West Columbia, SCNPI 1164596656
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.3% of the total across 39 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 20.9% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2020 at $276 and has fallen 85.8% since, to $39 in 2025. That places this record below the midpoint for podiatrist clinicians in SC, where the typical reported total is $1,261.
Across 39 payments — averaging $25.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Musculoskeletal Transplant Foundation Inc.$206
- Organogenesis Inc.$100
- Hartmann USA, Inc.$69
- Smith+Nephew$61
- Averitas Pharma Inc.$59
- Amgen$58
- plus $432 from 18 others
What the payments were for
- Food & beverage$94896%
- Education$374%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Musculoskeletal Transplant Foundation Inc. | 2 | $206 |
| Organogenesis Inc. | 3 | $100 |
| Hartmann USA, Inc. | 3 | $69 |
| Smith+Nephew | 3 | $61 |
| Averitas Pharma Inc. | 2 | $59 |
| Amgen | 2 | $58 |
| GRT US Holding, Inc. | 2 | $51 |
| Zyla Life Sciences, Inc. | 2 | $50 |
| Nabriva Therapeutics, PLC | 3 | $48 |
| AbbVie(2 entities) | 2 | $39 |
| Merck | 2 | $28 |
| Convatec Inc. | 1 | $27 |
| Abbott | 1 | $23 |
| Paratek Pharmaceuticals, Inc. | 1 | $21 |
| Novo Nordisk | 1 | $20 |
| ERMI LLC | 1 | $18 |
| Triad Life Sciences Inc. | 1 | $16 |
| Sebela Pharmaceuticals Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Novum Pharma, LLC | 1 | $14 |
| Cashflow Solutions, LLC | 1 | $13 |
| Melinta Therapeutics, LLC | 1 | $13 |
| Integra Lifesciences Corporation | 1 | $11 |
| Paragon 28, Inc. | 1 | $11 |
How this compares
$985 in reported general payments places this provider in the 45th percentile of 61 podiatrist providers in South Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clotrimazole | 197 | $6,077 |
| Ammonium Lactate | 126 | $2,257 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 124 | $1,757 |
| Ciclopirox | 14 | $1,736 |
| Ketoconazole | 68 | $1,550 |
| Triamcinolone Acetonide | 18 | $699 |
| Gabapentin | 55 | $649 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 13 | $535 |
| Diclofenac Sodium | 27 | $368 |
| Pregabalin | 17 | $323 |
| Mupirocin | 37 | $235 |
| Duloxetine Hcl | 14 | $152 |
| Tobramycin | 22 | $151 |
| Allopurinol | 20 | $148 |
| Doxycycline Hyclate | 13 | $63 |
Paid to pharmacies, not to this prescriber.
Other podiatrist in West Columbia
- Fernando Quirindongo SolanoWest Columbia$3K
- Jennifer KernWest Columbia$2K
- Kenice FrankWest Columbia$2K
- Marcela FarrerWest Columbia$1K
- Brandon PercivalLancaster$136K
- Alan BlockFlorence$96K
- William LongSimpsonville$91K
- Michael McCannFlorence$15K
- Daniel MethuselahIrmo$14K
- Breelyn MilesLadson$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.